DOCSLIB.ORG

The Calpain Inhibitor, BLD-2660, Has Robust Anti-Fibrotic Activity in a Rat Model of Non-Alcoholic Steatohepatitis Mozhdeh Sojoodi1, Smitha Krishnan1, Allen A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Calpain Inhibitor, BLD-2660, Has Robust Anti-Fibrotic Activity in a Rat Model of Non-Alcoholic Steatohepatitis Mozhdeh Sojoodi1, Smitha Krishnan1, Allen A The calpain inhibitor, BLD-2660, has robust anti-fibrotic activity in a rat model of non-alcoholic steatohepatitis Mozhdeh Sojoodi1, Smitha Krishnan1, Allen A. Razavi1, Michael R. Day1, Gunisha Arora1, Sarani Goshal1, Shen Li1, Derek J. Erstad1, Peter Caravan1, Kenneth K. Tanabe1, Maria E. Fuentes2, Bryan C. Fuchs1 1Massachusetts General Hospital, Harvard Medical School, Boston, United States 2BladeTherapeutics, Inc, South San Francisco, United States Background and aims Treatment of BLD-2660 decreases fibrosis. BID treatment of BLD-2660 was well-tolerated in CDAHFD rats Calpains are non-lysosomal Ca+ dependent cysteine proteases, which modulate different cellular A MC (BID) BLD-2660 (200mg/Kg, QD) BLD-2660 (60mg/Kg, QD) BLD-2660 (100mg/Kg, BID) BLD-2660 (30mg/Kg, BID) A pathways and have been involved in several diseases. Dimeric calpains (calpain 1, 2 and 9) QD L iv e r/B o d y W e ig h t B o d y W e ig h t function as obligate heterodimeric complexes between a large catalytic subunit (CAPN1, CAPN2 n s S p le e n /B o d y W e ig h t n s n s or CAPN9) and the small regulatory subunit (CAPNS1) to form the functional protease. The 5 0 0 ** 0 .0 8 0 .0 0 5 ** n s Sirius red dimeric calpains have been implicated in organ fibrosis in multiple rodent models, including 4 0 0 n s 0 .0 0 4 ** n s 0 .0 6 heart, lung and adipose tissue fibrosis. Inhibition or knock-out of dimeric calpain activity resulted 3 0 0 0 .0 0 3 r g % % 0 .0 4 in decrease fibrosis in these various models. 2 0 0 0 .0 0 2 ** 0 .0 2 Here we evaluated the effects of BLD-2660, a small molecule inhibitor of calpain 1, 2 and 9 1 0 0 0 .0 0 1 H&E Poster presented at: presented Poster provided by Blade Therapeutics Inc., in a rat model of non-alcoholic steatohepatitis (NASH). 0 0 .0 0 0 .0 0 0 C D g g C D g g C D g g K K K K K K N Q / / N Q / / N Q / / C g g C g g C g g M m m M m m M m m 0 0 0 0 0 0 0 6 0 6 0 6 2 2 2 Method BID SMA - L iv e r/B o d y W e ig h t S p le e n /B o d y W e ig h t α B o d y W e ig h t n s B * n s 5 0 0 ** 0 .0 8 Adult male Wistar rats (175-200 g) were fed either normal chow (NC) or a choline-deficient, L- * 0 .0 0 5 n s ** ** 4 0 0 n s amino acid-defined, high fat diet with 60 kcal% fat and 0.1% methionine (CDAHFD) for 12 B 0 .0 6 0 .0 0 4 3 0 0 weeks. After 5 weeks, rats were randomized to receive either vehicle control (0.5% r 0 .0 0 3 g % 0 .0 4 % QD 2 0 0 methylcellulose (MC), 200 mg/kg BLD-2660, or 60 mg/kg BLD-2660 by QD and 100 mg/kg 0 .0 0 2 0 .0 2 BLD-2660, or 30 mg/kg BLD-2660 by BID gavage (n = 8 per group). At the end of the study, 1 0 0 0 .0 0 1 liver tissue and serum were collected for further analysis. 0 0 .0 0 0 .0 0 0 C D g g C D g g g g I I C ID N /K /K N /K /K K K B B N B / / g g g g g g C C C m m m m m m M M M 0 0 0 0 0 0 0 3 0 3 0 3 1 1 1 DOI: 10.3252/pso.eu.ILC2019.2019 Results • Serum levels of Alanine transaminase (ALT), Alkaline phosphatase (ALP), Aspartate transaminase (AST) and Albumin did not change in CDAHFD rats that received BLD-2660 BID Fig4: Body weight, liver weight/body weight and spleen weight /body weight, as assessed at the time of sacrifice, remained stable in Expression of Calpain1 and 2 increased in a rat model of non-alcoholic steatohepatitis CDAHFD rats that received BLD-2660. N=8, Mean±SD, One-way ANOVA, **p < 0.01. NC = Normal Chow; 200 mg/Kg = BLD-2660 200 mg/kg one dose per day; 60 mg/Kg = BLD-2660 60 mg/kg one dose per day, MC BID = methyl cellulose twice per day; 100 mg/Kg = BLD-2660 100 mg/kg twice per day; 30 mg/Kg = BLD-2660 30 mg/kg twice per day. A Normal Chow (NC) 2 Weeks 8 Weeks 12 Weeks Conclusion In a rat model of NASH cirrhosis that more closely resembles the histology of human disease, Sirius red increase expression of calpain 1 and 2 was observed. Therapeutic treatment with 100 mg/kg BID Fig2: (A) Sirius Red, H&E and SMA staining on CDAHFD rats without drug (MC) and treated with BLD-2660. (B) BLD-2660, treated rats or 200 mg/kg QD of BLD-2660 showed reduction in fibrosis progression. No effect on steatosis have less fibrosis as measured by Collagen proportional area (CPA%), Hydroxy Proline and Smooth muscle actin (SMA) immunohistochemical staining. BLD-2660 did not change fat deposition in treated groups. N=8, Mean±SD, One-way ANOVA, *p < 0.05, was observed with the compound treatment. These results confirm the hypothesis that inhibiting **p < 0.01. Normal Chow; 200 mg/Kg = BLD-2660 200 mg/kg one dose per day; 60 mg/Kg = BLD-2660 60 mg/kg one dose per day, MC dimeric calpains represents a viable approach for an anti-fibrotic therapy. BID = methyl cellulose twice per day; 100 mg/Kg = BLD-2660 100 mg/kg twice per day; 30 mg/Kg = BLD-2660 30 mg/kg twice per day. H&E BID treatment of BLD-2660 decreased expression of pro-fibrotic genes in CDAHFD rats References B C D E S M A B C D C o l1 a 1 C a lp a in 1 C a lp a in 2 A C T G F IL -6 C A P N 2 1- McVicker, B. L. and R. G. Bennett (2017). "Novel Anti-fibrotic Therapies." Front Pharmacol 8: 318. C A P N 1 2 5 2 5 0 2 .0 8 2- Tabata, C., et al. (2010). "The calpain inhibitor calpeptin prevents bleomycin-induced pulmonary fibrosis in ** ** ns 2 0 * * 1 5 2 0 0 8 0 * * 1 5 0 4 ns mice." Clin Exp Immunol 162(3): 560-567. 1 .5 6 ** * n s 1 5 Q 1 5 0 * * n s 3- Younossi, Z., et al. (2018). "Global burden of NAFLD and NASH: trends, predictions, risk factors and Q Q Q * * * R 6 0 3 * R * R R 1 .0 4 * 1 0 1 0 1 0 0 * 1 0 0 * prevention." Nat Rev Gastroenterol Hepatol 15(1): 11-20. Q Q Q Q * R R 2 R 0 .5 2 R 4 0 5 5 0 4- Heidrich FM, Ehrlich BE (2009). Calcium, calpains, and cardiac hypertrophy: a new link. Circ Res. Jan 5 0 5 30;104(2):e19-20. 0 0 0 .0 0 2 0 1 C W W W C W W W C W W W C W W W N 2 6 2 N 2 6 2 N 2 6 2 N 2 6 2 5- uniappan L, et al. (2017). Calpain Inhibition Attenuates Adipose Tissue Inflammation and Fibrosis in Diet- 1 1 1 1 0 0 0 0 induced Obese Mice. Sci Rep. 31;7(1):14398. g g g g C D g g C D g g Cirrhosis and complications Mozhdeh Sojoodi C ID C ID I I K K K K N /K /K N /K /K N B / / N B / / B B Fig1: Histologic Sections of CDAHFD Rats. (A) H&E and Sirius Red staining indicate the progression of fat and Collagen g g g g g g g g C C C C 6- Ye T, et al. (2015). Over-expression of calpastatin inhibits calpain activation and attenuates post-infarction m m m m m m m m M M M M deposition, respectively, during 2, 6 and 12 weeks of CDAHFD. (B) Smooth muscle actin (SMA) and (C) Collagen expression 0 0 0 0 0 0 0 0 0 3 0 3 0 3 0 3 myocardial remodeling. PLoS One. 18;10(3):e0120178. increases gradually. (D, E) Calpain1 and Calpain 2 expression increases in CDAHFD rat model of NASH. N=3, Mean±SD, One-way 1 1 1 1 ANOVA, Compared to NC, *p < 0.05, **p < 0.01. NC = Normal Chow; 2W = 2 weeks after CDAHFD, 6W = 6 weeks after CDAHFD, Fig3: BLD-2660 (100 mg/Kg and 30 mg/Kg BID) decreased the expression of inflammatory markers (A-B) CTGF and IL-6. (E, F) 12W = 12 weeks after CDAHFD. Calpain 1 and 2 expression did not change after BID treatment of BLD-266D. NC N=3, BID, 100 mg/Kg and 30 mg/Kg N=8, Mean±SD, One-way ANOVA, *p < 0.05, **p < 0.01. NC = Normal Chow; MC BID = methyl cellulose twice per day; 100 mg/Kg = BLD- Any question? Please contact me [email protected] 2660 100 mg/kg twice per day; 30 mg/Kg = BLD-2660 30 mg/kg twice per day.
Load more

Recommended publications
  • Propranolol-Mediated Attenuation of MMP-9 Excretion in Infants with Hemangiomas
    Supplementary Online Content Thaivalappil S, Bauman N, Saieg A, Movius E, Brown KJ, Preciado D. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas. JAMA Otolaryngol Head Neck Surg. doi:10.1001/jamaoto.2013.4773 eTable. List of All of the Proteins Identified by Proteomics This supplementary material has been provided by the authors to give readers additional information about their work. © 2013 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 eTable. List of All of the Proteins Identified by Proteomics Protein Name Prop 12 mo/4 Pred 12 mo/4 Δ Prop to Pred mo mo Myeloperoxidase OS=Homo sapiens GN=MPO 26.00 143.00 ‐117.00 Lactotransferrin OS=Homo sapiens GN=LTF 114.00 205.50 ‐91.50 Matrix metalloproteinase‐9 OS=Homo sapiens GN=MMP9 5.00 36.00 ‐31.00 Neutrophil elastase OS=Homo sapiens GN=ELANE 24.00 48.00 ‐24.00 Bleomycin hydrolase OS=Homo sapiens GN=BLMH 3.00 25.00 ‐22.00 CAP7_HUMAN Azurocidin OS=Homo sapiens GN=AZU1 PE=1 SV=3 4.00 26.00 ‐22.00 S10A8_HUMAN Protein S100‐A8 OS=Homo sapiens GN=S100A8 PE=1 14.67 30.50 ‐15.83 SV=1 IL1F9_HUMAN Interleukin‐1 family member 9 OS=Homo sapiens 1.00 15.00 ‐14.00 GN=IL1F9 PE=1 SV=1 MUC5B_HUMAN Mucin‐5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 2.00 14.00 ‐12.00 MUC4_HUMAN Mucin‐4 OS=Homo sapiens GN=MUC4 PE=1 SV=3 1.00 12.00 ‐11.00 HRG_HUMAN Histidine‐rich glycoprotein OS=Homo sapiens GN=HRG 1.00 12.00 ‐11.00 PE=1 SV=1 TKT_HUMAN Transketolase OS=Homo sapiens GN=TKT PE=1 SV=3 17.00 28.00 ‐11.00 CATG_HUMAN Cathepsin G OS=Homo
    [Show full text]
  • Characterization of the Goose CAPN3 Gene and Its Expression Pattern in Muscle Tissues of Sichuan White Geese at Different Growth Stages
    http://www.jstage.jst.go.jp/browse/jpsa doi:10.2141/ jpsa.0170150 Copyright Ⓒ 2018, Japan Poultry Science Association. Characterization of the Goose CAPN3 Gene and its Expression Pattern in Muscle Tissues of Sichuan White Geese at Different Growth Stages Hengyong Xu*, Yahui Zhang*, Quan Zou, Liang Li, Chunchun Han, Hehe Liu, Jiwei Hu, Tao Zhong and Yan Wang Farm Animal Genetic Resources Exploration and Innovation Key Laboratory of Sichuan Province, Sichuan Agricultural University, Chengdu 611130, China Calpain 3 (CAPN3), also known as p94, is associated with multiple production traits in domestic animals. However, the molecular characteristics of the CAPN3 gene and its expression profile in goose tissues have not been reported. In this study, CAPN3 cDNA of the Sichuan white goose was cloned, sequenced, and characterized. The CAPN3 full-length cDNA sequence consists of a 2,316-bp coding sequence (CDS) that encodes 771 amino acids with a molecular mass of 89,019 kDa. The protein was predicted to have no signal peptide, but several N-glycosylation, O- glycosylation, and phosphorylation sites. The secondary structure of CAPN3 was predicted to be 38.65% α-helical. Sequence alignment showed that CAPN3 of Sichuan white goose shared more than 90% amino acid sequence similarity with those of Japanese quail, turkey, helmeted guineafowl, duck, pigeon, and chicken. Phylogenetic tree analysis showed that goose CAPN3 has a close genetic relationship and small evolutionary distance with those of the birds. qRT-PCR analysis showed that in 15-day-old animals, the expression level of CAPN3 was significantly higher in breast muscle than in thigh tissues.
    [Show full text]
  • Calpain System in Meat Tenderization: a Molecular Approach
    Revista MVZ Córdoba ISSN: 0122-0268 ISSN: 1909-0544 [email protected] Universidad de Córdoba Colombia Calpain System in meat tenderization: A molecular approach Coria, María S; Carranza, Pedro G; Palma, Gustavo A Calpain System in meat tenderization: A molecular approach Revista MVZ Córdoba, vol. 23, no. 1, 2018 Universidad de Córdoba, Colombia Available in: http://www.redalyc.org/articulo.oa?id=69355265012 DOI: https://doi.org/10.21897/rmvz.1247 This work is licensed under Creative Commons Attribution-ShareAlike 4.0 International. PDF generated from XML JATS4R by Redalyc Project academic non-profit, developed under the open access initiative María S Coria, et al. Calpain System in meat tenderization: A molecular approach Revisión de Literatura Calpain System in meat tenderization: A molecular approach El sistema proteolítico calpaina en la tenderización de la carne: Un enfoque molecular María S Coria DOI: https://doi.org/10.21897/rmvz.1247 Laboratorio de Producción Animal, Argentina Redalyc: http://www.redalyc.org/articulo.oa?id=69355265012 [email protected] Pedro G Carranza Universidad Nacional de Santiago del Estero, Argentina [email protected] Gustavo A Palma Universidad Nacional de Santiago del Estero, Argentina [email protected] Received: 02 October 2017 Accepted: 04 December 2017 Abstract: Tenderness is considered the most important meat quality trait regarding its eating quality. Post mortem meat tenderization is primarily the result of calpain mediated degradation of key proteins within muscles fibers. e calpain system originally comprised three molecules: two Ca2+-dependent proteases and a specific inhibitor. Numerous studies have shown that the calpain system plays a central role in postmortem proteolysis and meat tenderization.
    [Show full text]
  • Monoclonal Antibody to CAPNS1 - Purified
    OriGene Technologies, Inc. OriGene Technologies GmbH 9620 Medical Center Drive, Ste 200 Schillerstr. 5 Rockville, MD 20850 32052 Herford UNITED STATES GERMANY Phone: +1-888-267-4436 Phone: +49-5221-34606-0 Fax: +1-301-340-8606 Fax: +49-5221-34606-11 [email protected] [email protected] AM50627PU-S Monoclonal Antibody to CAPNS1 - Purified Alternate names: CAPN4, CAPNS, CSS1, Calcium-activated neutral proteinase small subunit, Calcium- dependent protease small subunit, Calcium-dependent protease small subunit 1, Calpain regulatory subunit, Calpain small subunit 1 Quantity: 50 µl Concentration: 1.0 mg/ml Background: CAPNS1, also known as Calpain small subunit 1, are a ubiquitous, well-conserved family of calcium-dependent, cysteine proteases. Calpain families have been implicated in neurodegenerative processes, as their activation can be triggered by calcium influx and oxidative stress. Calpain I and II are heterodimeric with distinct large subunits associated with common small subunits, all of which are encoded by different genes. Two transcript variants encoding the same protein have been identified for this gene. Uniprot ID: P04632 NCBI: NP_001740 Host / Isotype: Mouse / IgG1 Recommended Isotype SM10P (for use in human samples), AM03095PU-N Controls: Clone: AT1D11 Immunogen: Recombinant human CAPNS1 (84-268aa) purified from E. coli. Format: State: Liquid purified Ig fraction Purification: Protein-A affinity chromatography Buffer System: Liquid. In Phosphate-Buffered Saline (pH 7.4) with 0.02% Sodium Azide, 10% Glycerol. Applications: The antibody has been tested by ELISA, Western blot analysis, ICC/IF and Flow cytometry to assure specificity and reactivity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results.
    [Show full text]
  • Capns1 Regulates Usp1 Stability and Stem Cells Maintenance
    S. Passamonti, S. Gustincich, T. Lah Turnšek, B. Peterlin, R. Pišot, P. Storici (Eds.) CONFERENCE PROCEEDINGS with an analysis of innovation management CROSS-BORDER ITALY-SLOVENIA and knowledge transfer potential for a smart specialization strategy BIOMEDICAL RESEARCH: ISBN 978-88-8303-572-2 / e-ISBN 978-88-8303-573-9. EUT, 2014. ARE WE READY FOR HORIZON 2020? CAPNS1 REGULATES USP1 STABILITY AND STEM CELLS MAINTENANCE Francesca Cataldo and Francesca Demarchi CIB National Laboratory, Area Science Park, Padriciano 99, 34149 Trieste Abstract — Calpains are a family of calcium-related cysteine-proteases that are involved in a wide number of cellular processes. The ubiquitous calpains, micro- and milli-calpain, are heterodimers composed of catalytic subunits and a common regulatory subunit, encoded by CAPNS1. We identified USP1 deubiquitinase as a CAPNS1-interacting protein. USP1 is a key modulator of DNA repair, partly through deubiquitination of its known targets FANCD2 and PCNA. Usp1 knockout mice have a severe phenotype and die soon after birth. Usp1−/− cells are defective in FANCD2 focus formation and are hypersensitive to DNA damage. PCNA ubiquitination is higher in USP1-depleted cells than in control cells, thus leading to recruitment of error-prone, translesion DNA synthesis (TLS) polymerases and the consequent increase in mutation rate. USP1 promotes inhibitor of DNA binding (ID) protein stability and stem cell-like characteristics in osteosarcoma and is required for normal skeletogenesis. We found that the ubiquitinated form of the USP1 substrate PCNA is stabilized in CAPNS1-depleted U2OS cells and mouse embryonic fibroblasts (MEFs), favoring polymerase-η loading on chromatin and increased mutagenesis.
    [Show full text]
  • Calpain-2 Participates in the Process of Calpain-1 Inactivation
    Bioscience Reports (2020) 40 BSR20200552 https://doi.org/10.1042/BSR20200552 Research Article Calpain-2 participates in the process of calpain-1 inactivation Fumiko Shinkai-Ouchi1, Mayumi Shindo2, Naoko Doi1, Shoji Hata1 and Yasuko Ono1 1Calpain Project, Department of Basic Medical Sciences, Tokyo Metropolitan Institute of Medical Science (TMiMS), 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156- 8506, Japan; 2Center for Basic Technology Research, Tokyo Metropolitan Institute of Medical Science (TMiMS), 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156- 8506, Japan Downloaded from http://portlandpress.com/bioscirep/article-pdf/40/11/BSR20200552/896871/bsr-2020-0552.pdf by guest on 28 September 2021 Correspondence: Yasuko Ono ([email protected]) Calpain-1 and calpain-2 are highly structurally similar isoforms of calpain. The calpains, a family of intracellular cysteine proteases, cleave their substrates at specific sites, thus modifying their properties such as function or activity. These isoforms have long been considered to function in a redundant or complementary manner, as they are both ubiq- uitously expressed and activated in a Ca2+- dependent manner. However, studies using isoform-specific knockout and knockdown strategies revealed that each calpain species carries out specific functions in vivo. To understand the mechanisms that differentiate calpain-1 and calpain-2, we focused on the efficiency and longevity of each calpain species after activation. Using an in vitro proteolysis assay of troponin T in combination with mass spectrometry, we revealed distinctive aspects of each isoform. Proteolysis mediated by calpain-1 was more sustained, lasting as long as several hours, whereas proteolysis me- diated by calpain-2 was quickly blunted.
    [Show full text]
  • An Elaborate Proteolytic System☆
    Biochimica et Biophysica Acta 1824 (2012) 224–236 Contents lists available at SciVerse ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbapap Review Calpains — An elaborate proteolytic system☆ Yasuko Ono ⁎, Hiroyuki Sorimachi ⁎ Calpain Project, Department of Advanced Science for Biomolecules, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan article info abstract Article history: Calpain is an intracellular Ca2+-dependent cysteine protease (EC 3.4.22.17; Clan CA, family C02). Recent Received 14 April 2011 expansion of sequence data across the species definitively shows that calpain has been present throughout Received in revised form 3 August 2011 evolution; calpains are found in almost all eukaryotes and some bacteria, but not in archaebacteria. Fifteen Accepted 5 August 2011 genes within the human genome encode a calpain-like protease domain. Interestingly, some human calpains, Available online 16 August 2011 particularly those with non-classical domain structures, are very similar to calpain homologs identified in evolutionarily distant organisms. Three-dimensional structural analyses have helped to identify calpain's Keywords: Calpain unique mechanism of activation; the calpain protease domain comprises two core domains that fuse to form a 2+ Calcium ion functional protease only when bound to Ca via well-conserved amino acids. This finding highlights the Protease mechanistic characteristics shared by the numerous calpain homologs, despite the fact that they have Skeletal muscle divergent domain structures. In other words, calpains function through the same mechanism but are Gastric system regulated independently. This article reviews the recent progress in calpain research, focusing on those Proteolysis studies that have helped to elucidate its mechanism of action.
    [Show full text]
  • A Calcium-Dependent Protease As a Potential Therapeutic Target for Wolfram Syndrome
    A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome Simin Lua,b, Kohsuke Kanekuraa, Takashi Haraa, Jana Mahadevana, Larry D. Spearsa, Christine M. Oslowskic, Rita Martinezd, Mayu Yamazaki-Inouee, Masashi Toyodae, Amber Neilsond, Patrick Blannerd, Cris M. Browna, Clay F. Semenkovicha, Bess A. Marshallf, Tamara Hersheyg, Akihiro Umezawae, Peter A. Greerh, and Fumihiko Uranoa,i,1 aDepartment of Medicine, Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, MO 63110; bGraduate School of Biomedical Sciences, University of Massachusetts Medical School, Worcester, MA 01655; cDepartment of Medicine, Boston University School of Medicine, Boston, MA 02118; dDepartment of Genetics, iPSC core facility, Washington University School of Medicine, St. Louis, MO 63110; eDepartment of Reproductive Biology, National Center for Child Health and Development, Tokyo 157-8535, Japan; fDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110; gDepartments of Psychiatry, Neurology, and Radiology, Washington University School of Medicine, St. Louis, MO 63110; hDepartment of Pathology and Molecular Medicine, Queen’s University, Division of Cancer Biology and Genetics, Queen’s Cancer Research Institute, Kingston, Ontario K7L3N6, Canada; and iDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110 Edited by Stephen O’Rahilly, University of Cambridge, Cambridge, United Kingdom, and approved November 7, 2014 (received for review November 4, 2014) Wolfram syndrome is a genetic disorder characterized by diabetes gene variants are also associated with a risk of type 2 diabetes (17). and neurodegeneration and considered as an endoplasmic re- Moreover, a specific WFS1 variant can cause autosomal dominant ticulum (ER) disease.
    [Show full text]
  • Calpain-5 Expression in the Retina Localizes to Photoreceptor Synapses Kellie A
    University of Kentucky UKnowledge Spinal Cord and Brain Injury Research Center Spinal Cord and Brain Injury Research Faculty Publications 5-2016 Calpain-5 Expression in the Retina Localizes to Photoreceptor Synapses Kellie A. Schaefer University of Iowa Marcus A. Toral University of Iowa Gabriel Velez University of Iowa Allison J. Cox University of Iowa Sheila A. Baker University of Iowa See next page for additional authors Right click to open a feedback form in a new tab to let us know how this document benefits oy u. Follow this and additional works at: https://uknowledge.uky.edu/scobirc_facpub Part of the Neurology Commons Repository Citation Schaefer, Kellie A.; Toral, Marcus A.; Velez, Gabriel; Cox, Allison J.; Baker, Sheila A.; Borcherding, Nicholas C.; Colgan, Diana F.; Bondada, Vimala; Mashburn, Charles B.; Yu, Chen Guang; Geddes, James W.; Tsang, Stephen H.; Bassuk, Alexander G.; and Mahajan, Vinit B., "Calpain-5 Expression in the Retina Localizes to Photoreceptor Synapses" (2016). Spinal Cord and Brain Injury Research Center Faculty Publications. 12. https://uknowledge.uky.edu/scobirc_facpub/12 This Article is brought to you for free and open access by the Spinal Cord and Brain Injury Research at UKnowledge. It has been accepted for inclusion in Spinal Cord and Brain Injury Research Center Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact [email protected]. Authors Kellie A. Schaefer, Marcus A. Toral, Gabriel Velez, Allison J. Cox, Sheila A. Baker, Nicholas C. Borcherding, Diana F. Colgan, Vimala Bondada, Charles B. Mashburn, Chen Guang Yu, James W. Geddes, Stephen H. Tsang, Alexander G.
    [Show full text]
  • Comprehensive Analysis of the Prognostic Value and Immune in Ltration of Calpains in Pancreatic Cancer
    Comprehensive Analysis of the Prognostic Value and Immune Inltration of Calpains in Pancreatic Cancer Lan Chuan Aliated Hospital of North Sichuan Medical College https://orcid.org/0000-0002-6101-222X Haoyou Tang Aliated Hospital of North Sichuan Medical College Sheng Liu Aliated Hospital of North Sichuan Medical College Lin Ma Aliated Hospital of North Sichuan Medical College Yifu Hou ( [email protected] ) University of Electronic Science and Technology of China Research Keywords: bioinformatics analysis, calpains, pancreatic cancer, prognosis, immune inltration Posted Date: August 3rd, 2021 DOI: https://doi.org/10.21203/rs.3.rs-716693/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/30 Abstract Background: Calpains (CAPNs) are intracellular calcium-activated neutral cysteine proteinases that are involved in cancer initiation, progression, and metastasis; however, their role in pancreatic cancer (PC) remains unclear. Methods: We combined data from various mainstream databases (i.e., Oncomine, GEPIA, Kaplan-Meier plotter, cBioPortal, STRING, GeneMANIA, and ssGSEA) and investigated the role of CAPNs in the prognosis of PC and immune cell inltration. Results: Our results showed that CAPN1, 2, 4, 5, 6, 8, 9, 10, and 12 were highly expressed in PC. The expression levels of CAPN1, 5, 8, and 12 were positively correlated with the individual cancer stages. Moreover, the expression levels of CAPN1, 2, 5, and 8 were negatively correlated with the overall survival (OS) and recurrence-free survival (RFS); whereas that of CAPN10 was positively correlated with OS and RFS. We found that CAPN1, 2, 5, and 8 were correlated with tumour-inltrating T follicular helper cells and CAPN10 with tumour-inltrating T helper 2 cells.
    [Show full text]
  • FASEB SRC “Biology of Calpains in Health and Disease” Co-Organizers: James Geddes and Peter Greer July 21-26, 2013, Saxtons
    FASEB SRC “Biology of Calpains in Health and Disease” Co-Organizers: James Geddes and Peter Greer July 21-26, 2013, Saxtons River, Vermont, USA Introduction: 12:00~12:15, July 23 (Tue), 2013 Discussion: 11:30~12:15, July 24 (Wed), 2013 Revised: September 20 (Fri), 2013 Calpain nomenclature Ref: http://www.calpain.net/ Hiro Sorimachi, IGAKUKEN Peter Davies, Queen’s University A brief history of structures of the conventional calpains Present situation: • Two different numbering exist. • “domain I” is too small to be called domain. Proposed domain structure, color, and nomenclature CysPc: calpain-like cysteine protease core motif [cd00044] defined in the conserved domain database (CDD) of National Center for Biotechnology Information (NCBI). Calpain domain nomenclature MIT: microtubule interaction and transport TML: long transmembrane motif SOL SOL: small optic lobes TPR Zf: zinc-finger motif TPR: tetratricopeptide repeats UBA: ubiquitin associated domain PUB: Peptide:N-glycanase/UBA or UBX-containing Calpain subunit name = Gene product name Human gene Chr. location Gene product Aliases Classical? Ubiquitous? Catalytic subunits μ-calpain large subunit (μCL), CAPN1 11q13 CAPN1 ✔ ✔ μCANP/calpain-I large subunit, μ80K m-calpain large subunit (mCL), CAPN2 1q41-q42 CAPN2 ✔ ✔ mCANP/calpain-II large subunit, m80K CAPN3 15q15.1-q21.1 CAPN3 p94, calpain-3, calpain-3a, nCL-1 ✔ CAPN5 11q14 CAPN5 hTRA-3, nCL-3 ✔ CAPN6 Xq23 CAPN6 calpamodulin, CANPX CAPN7 3p24 CAPN7 PalBH ✔ CAPN8 1q41 CAPN8 nCL-2, calpain-8, calpain-8a ✔ CAPN9 1q42.11-q42.3 CAPN9 nCL-4, calpain-9, calpain-9a ✔ CAPN10 2q37.3 CAPN10 calpain-10a (exon 8 is skipped) ✔ CAPN11 6p12 CAPN11 ✔ CAPN12 19q13.2 CAPN12 calpain-12a, calpain-12A ✔ CAPN13 2p22-p21 CAPN13 ✔ ✔ CAPN14 2p23.1-p21 CAPN14 ✔ ✔ CAPN15/SOLH 16p13.3 CAPN15 SOLH ✔ CAPN16/C6orf103 6q24.3 CAPN16 Demi-calpain, C6orf103 ✔ Regulatory subunits CAPNS1 19q13.1 CAPNS1 CANP/calpain small subunit, 30K, css1, CAPN4 n.a.
    [Show full text]
  • Probing the Ige-Binding Repertoire of Self-Antigens in Atopic Eczema
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2009 Probing the IgE-Binding Repertoire of Self-Antigens in Atopic Eczema Zeller, S Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-31226 Dissertation Originally published at: Zeller, S. Probing the IgE-Binding Repertoire of Self-Antigens in Atopic Eczema. 2009, University of Zurich, Faculty of Science. Probing the IgE-Binding Repertoire of Self-Antigens in Atopic Eczema Dissertation zur Erlangung der naturwissenschaftlichen Doktorwürde (Dr. sc. nat.) vorgelegt der Mathematisch-naturwissenschaftlichen Fakultät der Universität Zürich von Sabine Zeller aus Deutschland Promotionskomitee Prof. Dr. Roland H. Wenger (Vorsitz) Prof. Dr. Reto Crameri (Leitung der Dissertation) PD Dr. Peter Schmid-Grendelmeier Zürich, 2009 Publications Original Articles 1. Zeller S, Rhyner C, Meyer N, Schmid-Grendelmeier P, Akdis CA, Crameri R. Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema. Journal of Allergy and Clinical Immunology (accepted for publication) 2. Zeller S, Johansson C, Rhyner C, Scheynius A, Crameri R. The IgE-binding self- antigens tubulin-α and HLA-DR-α are overexpressed in the lesional skin of atopic eczema patients. Allergy (submitted) Review Article 1. Zeller S, Glaser AG, Vilhelmsson M, Rhyner C, Crameri R. Immunoglobulin-E- mediated reactivity to self-antigens: a controversial issue. International Archives of Allergy
    [Show full text]